Flexible Solutions International, Inc.FSI
Recorded

Flexible Solutions International, Inc. 2026 Q2 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ2 2026Duration25 minParticipants6

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Good day everyone, and welcome to the Flexible Solutions International Second Quarter 2026 conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session. You may register to ask a question at any time by pressing star 1. Please note this call is being recorded and I will be standing by for assistance. Now, I will turn the call over to your host, Dan O'Brien.

Dan O'BrienCEO

Please go ahead. Thank you, Elvis.

Dan O'BrienCEO

Good morning. I am Dan O'Brien, CEO of Flexible Solutions. Safe harbor provision. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements. Certain of the statements contained herein, which are not historical facts, are forward-looking statements with respect to events, the occurrence of which involve risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company is detailed from time to time in the company's reports filed with the Securities and Exchange Commission. Welcome to the FSI conference call for second quarter 2026. I will start by reviewing our company condition and our product lines, along with what we think may occur in Q3 and Q4 2026. I will comment on our financials in the second part of the speech. NanoChem division. NCS. It is one of the three major revenue sources for FSI.

Dan O'BrienCEO

In 2022, NanoChem Solutions started food-grade operations. By the end of 2026, we expect that NanoChem Solutions will be 100% focused on food-grade products. Growth in the NanoChem Solutions division will be in food and nutraceuticals only. The Illinois plant is FDA and SQF certified, and we have commercialized two food products. The first was a wine additive based on polyaspartates. In August 2025, we announced our second major food-grade contract of 2025 and our third overall. As noted in the news releases, it is a five-year contract with protections from tariffs and inflation. It has a minimum revenue of $6.5 million per year. This contract has reached full production and is being optimized to ensure that it is profitable. In January 2025, we announced our largest food-grade contract.

Dan O'BrienCEO

Volume production started very late in Q2 and will be increased weekly until full production is achieved. Significant revenue from this contract will be visible in our Q3 financials and will increase rapidly in Q4. Growing these two food contracts to the estimated maximum revenues of greater than $50 million per year is our critical goal for the next four to six quarters. We hope to execute this to the customer's absolute satisfaction and obtain all their business before taking on additional major projects. This does not mean that we are not looking for more customers. We are already doing R&D work in certain areas. However, it does mean that several quarters are likely to elapse before other major customers are announced. We would also like to be clear regarding margins in the food division.

Dan O'BrienCEO

In order to obtain such large contracts and in order to negotiate tariff and inflation protection clauses, we have lower margins than we prefer. We hope to be in the 22%-25% range before tax. Future customers will be selected in order to increase our average margins now that we have a base in place. The Panama division. This division, our second major revenue source, makes thermal polyaspartic acid, called TPA for short, a biodegradable polymer with many valuable uses. Panama also manufactures SUN 27 and N Savr 30, which are used to reduce nitrogen fertilizer loss from soil. Panama is taking over production of all the legacy industrial and agricultural products historically made by NanoChem Solutions. This is a step-by-step process that will be complete by the end of 2026. TPA is used in agriculture to significantly increase crop yield.

Dan O'BrienCEO

TPA is a biodegradable way of treating oil field water for scale prevention. It is sold as a biodegradable ingredient in cleaning products and as a water treatment chemical. In Q2, Panama production increased. However, the poor performance by the FL LLC customer and poor agriculture sales impacted revenue. Q3 has been much better as a result of selling direct to the FL LLC customers and orders from legacy NanoChem customers. We expect Panama to be a strong contributor to revenue and profits in Q3 and thereafter. Our Panama factory results in reduced shipping times and no exposure to U.S. tariffs on international sales, which could allow us to increase sales to existing customers and obtain new customers. The ENP division. ENP is our third major source of revenue, and ENP is focused on sales into the greenhouse, turf, and golf markets. ENP grew in 2025. Its growth expected again in 2026.

Dan O'BrienCEO

Q2 is a weak quarter, and it was very weak this year. Q3 is already showing a significant rebound. Agricultural products in the U.S. remain under extreme pressure. Crop prices are still not increasing at the rate of inflation, and extreme uncertainty is present due to tariff changes, energy costs, and fertilizer scarcity. Growers are facing a conflict between rising costs and low crop prices, aggravated by political actions and war. In some cases, sales are lost for the whole season, and as a result, we saw weakness in Q2 and expect 2026 to be another difficult year. The FL LLC investment. In August 2024, the company sold 30.1% of the equity in the FL LLC to an acquirer for $2 million and five annual payments of $800,000. The acquirer was unable to fund the annual payments.

Dan O'BrienCEO

As a result, the company has been granted the perpetual exclusive rights to four agricultural products and the IP of these products in the exclusive territory. The territory is defined as south of the Mexico-U.S. border, including all of Central America, South America, and the Caribbean. We have been making these products for these countries for a decade and believe that now that we have the sales rights for them, lost sales can be recovered, and the historic revenue we saw from the FL LLC investment can be realized again. Full revenue recovery will not be immediate, but we have made progress already. This revenue will be evident in Q3. Tariffs. The current tariff on all of our imports from raw materials from China into the U.S. is between 15% and 58%, depending on the material. Shipping and inventory. Shipping prices are not stable.

Dan O'BrienCEO

Shipping times are longer than usual on the routes we use. These issues are caused by the Iran war, and they are expected to subside if the war does. Raw material prices are unstable and increasing to account for the oil prices caused by the Iran war. We have a significant inventory of most raw materials, but we anticipate that we will have to raise prices to our customers in the third or fourth quarter, unless there is a significant reduction in the price of oil that reduces our raw material costs. The highlights of the financial results. Sales for the quarter decreased by 14% compared to Q2 2025, $7.60 million versus $8.87 million. The 2025 quarter included $2.5 million of irregular revenue from R&D activity that did not recur in 2026. With this removed, recurring revenue was higher year-over-year. Profits. 2026 recorded a loss of $1.91 million, or $0.15 per share, compared to a gain of $2.03 million or $0.16 a share in the 2025 period.

Dan O'BrienCEO

Costs incurred in scaling up the food-grade contracts announced in January and August of 2025 negatively affected Q2 profits because they are expensed as they occur. Scale-up costs for the Panama factory are also expensed quarter by quarter. This continued in Q2 2026 in Panama and for food products in Illinois at lower levels, but without sufficient revenue to avoid the losses. We anticipate a return to profitability in Q3, followed by rapidly increasing profits in Q4. Long-term debt. We continue to pay down our long-term debt according to the terms of the loans. We have one small term loan and the small mortgage on our Illinois factory remaining. Our working capital is adequate for all our purposes.

Dan O'BrienCEO

We have lines of credit with Stock Yards Bank & Trust for ENP and the NanoChem Solutions subsidiaries. We are confident that we can execute our plans with our existing capital and without resorting to any equity actions. The text of this speech will be available as an 8K filing on www.sec.gov by Tuesday, August 18th, and email copies can be requested from Jason Bloom, jason@flexiblesolutions.com. Thank you. The floor is open for questions. Elvis, will you put all that together for us, please?

Operator

Certainly, Dan. If you would like to ask a question, please press star one on your phone now and you will be queued in order. Again, star one for a question, and we will pause briefly to form our queue. First, we have Alan Markham of Van Clemens & Co. Incorporated. Please go ahead. Hi, Dan.

Alan MarkhamFinancial Advisor

Thanks for that info. Can you elaborate a little bit more? You are mentioning the higher raw material cost that I believe led to the larger than expected inventories. I believe that was listed on the 10-Q that inventories were historically higher than past. Can I make that connection? Does that make sense? Yes.

Dan O'BrienCEO

We have been banking inventory rather than money, because there were low prices last fall for certain of our products. We took advantage of that, especially in Panama. We will probably try and achieve that again this fall. One of our primary products, Alan, this is your first time asking questions, and welcome.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

More recent earnings calls

View earnings calendar